Therapeutic Plasma Exchange in a rare case myasthenic crisis after Botox injection

Atherosclerosis Supplements

Volumn 30, Issue , 2017, Pages 283-285

  Chegini, Azita ^a  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Blood component removal; Botulinum toxins; Myasthenia gravis

Indexed keywords

AMANTADINE; BOTULINUM TOXIN A; IMMUNOGLOBULIN; PREDNISOLONE; ACETYLCHOLINE RELEASE INHIBITOR; AUTOANTIBODY; BIOLOGICAL MARKER; NICOTINIC RECEPTOR;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BREATHING MUSCLE; CASE REPORT; CLINICAL ARTICLE; DYSARTHRIA; DYSPNEA; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHYROIDISM; INTUBATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PHYSICAL EXAMINATION; PLASMA EXCHANGE; PRIORITY JOURNAL; PTOSIS; RESPIRATORY DISTRESS; SPEECH DISORDER; SWALLOWING; BLOOD; BOTULISM; CHEMICALLY INDUCED; COMPLICATION; ESTHETIC SURGERY; IMMUNOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACETYLCHOLINE RELEASE INHIBITORS; ADULT; AUTOANTIBODIES; BIOMARKERS; BOTULINUM TOXINS, TYPE A; BOTULISM; COSMETIC TECHNIQUES; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; RECEPTORS, NICOTINIC; TREATMENT OUTCOME;

EID: 85032445024     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2017.05.016     Document Type: Article

References (13)

1. Pinching, A.J., Peters, D.K., Remission of myasthenia gravis following plasma-exchange. Lancet 2:8000 (1976), 1373–1376.
2. Kasper, D., Fauci, A., Hauser, S., Longo, D., Jameson, J., Loscalzo, J., Harrison's principles of internal medicine. 19th ed., 2015, McGraw-Hill Education, New York, 2704–2706.
3. MCLeod, B.C., Weinstein, R., Winters, J.L., Textbook of apheresis principles and practice. 3rd ed., 2010, AABB, USA, 295–317.
4. King Karen, E., Bandarenko, N., Blood Transfusion therapy (a physician's handbook). 11th ed., 2014, AABB, USA, 217–224.
5. Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R.A., Connelly-Smith, L., Delaney, M., et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for apheresis: the seventh special issue. J Clin Apher 31:3 (2016 Jun 1), 149–162.
6. Roback, D.J., Combs, M.R., Grossman, B.J., Hillyer, C.D., Technical manual., 16th ed, 2008, AABB, USA, 697–711.
7. Klein, H.G., Anstee, D.J., Mollison's blood transfusion in clinical medicine. 12th ed., 2014, 782–783.
8. Nigam, P.K., Nigam, A., Botulinum toxin. Indian J Dermatol 55:1 (2010), 8–14.
9. Benedetto, A.V., The cosmetic uses of Botulinum toxin type A. Int J Dermatol 38:9 (1999), 641–655.
10. Giotzolou, T., Cordivari, C., Lee, P.J., Hanna, M.G., Lees, A.J., Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry 76:11 (2005), 1594–1596.
11. Patel, V., Elston, J., Malhotra, R., Prolonged effect of botulinum toxin – a treatment in patients with myasthenia gravis. J Clin Exp Ophthalmol, 2, 2011, 3.
12. Richman, D.P., Agius, M.A., Treatment of autoimmune myasthenia gravis. Neurology 61:12 (2003), 1652–1661.
13. Romi, F., Gihus, N.E., Aarli, J.A., Myasthenia gravis: clinical, immunological and therapeutic advances. Acta Neurol Scand 111:2 (2005), 134–141.